metaiodobenzylguanidine
Small moleculeexperimentalImaging agent
Iobenguane, or MIBG, is an aralkylguanidine analog of the adrenergic neurotransmitter norepinephrine (noradrenaline), typically used as a radiopharmaceutical. It acts as a blocking agent for adrenergic neurons. When radiolabeled, it can be used in nuclear medicinal diagnostic and therapy techniques as well as in neuroendocrine chemotherapy treatments. — Wikipedia
Clinical trial activity
11 trials · 12 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
4
Phase 3
0
Phase 4
1
Earliest trial started Apr 1, 2000 (NCT01370330)
Timeline
Indications
Approved for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 124-iodine
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaIobenguane ↗
Also known as
- 124i-mibg
- 124i-mibg
- metaiodobenzylguanidine
- metaiodobenzylguanidine
- mibg
- mibg
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06965621 | Phase 2 | Nov 30, 2025 | Illumina, Inc., University of Texas, Galveston |
| NCT05514106 | Phase 4 | Dec 31, 2022 | Mayo Clinic |
| NCT03649438 | Early Phase 1 (Phase 1) | Sep 4, 2018 | The University of Texas, Dallas |
| NCT02771743 | Phase 2 | Apr 1, 2015 | Sungkyunkwan University |
| NCT02378428 | Phase 2 | Mar 1, 2014 | Ohio State University |
| NCT01583842 | N/A | Jun 1, 2012 | University of California, San Francisco |
| NCT01313936 | N/A | Mar 1, 2011 | Thrasher Research Fund, University of California, San Francisco |
| NCT01185756 | N/A | Sep 1, 2010 | University of Paris |
| NCT00389766 | Phase 2 | Jul 1, 2008 | Children's Cancer and Leukaemia Group, University of London |
| NCT00790413 | Early Phase 1 (Phase 1) | Aug 1, 2005 | Lund University |
| NCT01370330 | N/A | Apr 1, 2000 | University of California, San Francisco |
Showing 11 of 11 trials
Page 1 / 1
Organizations
Research & Development (12)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of California, San Francisco | Academic/Hospital | 3 | 3 | 1 | 2000 |
| Children's Cancer and Leukaemia Group | Academic/Hospital | 1 | 1 | 1 | 2008 |
| Illumina, Inc. | For profit | 1 | 1 | 1 | 2025 |
| Lund University | Academic/Hospital | 1 | 1 | 1 | 2005 |
| Mayo Clinic | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Ohio State University | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Sungkyunkwan University | Academic/Hospital | 1 | 1 | 1 | 2015 |
| The University of Texas, Dallas | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Thrasher Research Fund | Academic/Hospital | 1 | 0 | 1 | 2011 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2008 |
| University of Paris | Academic/Hospital | 1 | 1 | 1 | 2010 |
| University of Texas, Galveston | Academic/Hospital | 1 | 0 | 1 | 2025 |
12 organizations
Page 1 / 1